Table Of ContentJOURNAL OF THE
NEUROLOGICAL
SCIENCES
my A RATS4
ELSEVIER
Journal of the Neurological Sciences 145 (1997) 221-223
Author Index (Vol. 145)
Aarli, J.A. Filla, A., see Trouillas, P. (145) 205
Neurology and public health: strategy and perspectives (145) 3 Fogel, W., see Hund, E. (145) 25
Akalin, T., see Dean, G. (145) 163 Forsting, M., see Hund, E. (145) 25
Akaoka, I., see Matsumoto, R. (145) 147 Fujita, N., see Kishi, T. (145) 109
Aksoy, H., see Dean, G. (145) 163
Alberto, J., see Janca, A. (145) 1 Gartner, M., see Veuillet, E. (145) 69
Arden, G.B., see Plant, G.T. (145) 127 Gasalla, T., see Jiménez-Jiménez, F.J. (145) 183
Arenas, J., see Jiménez-Jiménez, F.J. (145) 183 Gibson, K., see Van Belle, G. (145) 141
Asahina, T., see Suzuki, Y. (145) 49
Giovannoni, G., Heales, S.J.R., Silver, N.C., O’Riordan, J., Miller, R.F.,
Atsumi, Y., see Suzuki, Y. (145) 49
Land, J.M., Clark, J.B. and Thompson, E.J.
Ausenda, C.D., see Del Bo, R. (145) 87
Raised serum nitrate and nitrite levels in patients with multiple
sclerosis (145) 77
Baig, S.M. Goebel, H.H., see Hund, E. (145) 25
Acetazolamide therapy improves action myoclonus in Ramsay Hunt Gomez, C.M., see Trouillas, P. (145) 205
Syndrome (145) 123 Goto, I., see Taniwaki, T. (145) 63
Ben Hamida, M., see Trouillas, P. (145) 205 Goto, Y.-i., see Suzuki, Y. (145) 49
Benito-Leén, J., see Jiménez-Jiménez, F.J. (145) 183 Grau, A., see Hund, E. (145) 25
Berkovic, S.F., see Marzuki, S. (145) 155 Gregson, N.A., see Khalili-Shirazi, A. (145) 169
Blain, H., see Merched, A. (145) 33
Bresolin, N., see Del Bo, R. (145) 87 Habgood, J.J., see Orrell, R.W. (145) 55
Bryer, A., see Trouillas, P. (145) 205 Hall, M.A., see Khalili-Shirazi, A. (145) 169
Byrne, E., see Marzuki, S. (145) 155 Hallett, M., see Trouillas, P. (145) 205
Harzer, K., see Hund, E. (145) 25
Campanella, G., see Trouillas, P. (145) 205 Heales, S.J.R., see Giovannoni, G. (145) 77
Campos, Y., see Jiménez-Jiménez, F.J. (145) 183 Heiss, W.-D., Karbe, H., Weber-Luxenburger, G., Herholz, K., Kessler,
Cantz, M., see Hund, E. (145) 25 J., Pietrzyk, U. and Pawlik, G.
Castelli, E., see Del Bo, R. (145) 87 Speech-induced cerebral metabolic activation reflects recovery from
Champsaur, G., see Veuillet, E. (145) 69 aphasia (145) 213
Cheng, Y., see Ng, H.-k. (145) 97 Herbeth, B., see Merched, A. (145) 33
Chopp, M., see Jiang, Q. (145) 15 Herholz, K., see Heiss, W.-D. (145) 213
Clark, J.B., see Giovannoni, G. (145) 77 Herroelen, L., see De Keyser, J. (145) 93
Collet, L., see Veuillet, E. (145) 69 Honnorat, J., see Trouillas, P. (145) 205
Comi, G.P., see Del Bo, R. (145) 87 Hoshiyama, M., see Kitamura, Y. (145) 187
Conti, E., see Del Bo, R. (145) 87 Hosokawa, K., see Suzuki, Y. (145) 49
Coutinho, P., see Trouillas, P. (145) 205 Hughes, R.A.C., see Khalili-Shirazi, A. (145) 169
Currier, R.D., see Trouillas, P. (145) 205 Hund, E., Grau, A., Fogel, W., Forsting, M., Cantz, M., Kustermann-
Kuhn, B., Harzer, K., Navon, R., Goebel, H.H. and Meinck, H.-M.
Dean, G., Aksoy, H., Akalin, T., Middleton, L. and Kyriallis, K. Progressive cerebellar ataxia, proximal neurogenic weakness and
Multiple sclerosis in the Turkish- and Greek-speaking communities of ocular motor disturbances: hexosaminidase A deficiency with late
Cyprus. A United Nations (UNHCR) Bicommunal Project (145) 163 clinical onset in four siblings (145) 25
De Belleroche, J.S., see Orrell, R.W. (145) 55 Hung, T.-p., see Nishimura, K. (145) 5
Degiuli, A., see Del Bo, R. (145) 87
De Keyser, J., Herroelen, L. and De Klippel, N. Ichiya, Y., see Taniwaki, T. (145) 63
Early outcome in acute ischemic stroke is not influenced by the Iwata, M., see Shibata, K. (145) 177
prophylactic use of low-dose aspirin (145) 93
De Klippel, N., see De Keyser, J. (145) 93 Jacobs, M., see Jiang, Q. (145) 15
Del Bo, R., Comi, G.P., Bresolin, N., Castelli, E., Conti, E., Degiuli, A., Janca, A., Prilipko, L., Alberto, J. and Silva, C.
Ausenda, C.D. and Scarlato, G. The World Health Organization’s global initiative on neurology and
The apolipoprotein E €4 allele causes a faster decline of cognitive public health (145) 1
performances in Down’s syndrome subjects (145) 87 Jeandel, C., see Merched, A. (145) 33
Diener, H.C., see Trouillas, P. (145) 205 Jiang, Q., Chopp, M., Zhang, Z.G., Knight, R.A., Jacobs, M., Windham,
J.P., Peck, D., Ewing, J.R. and Welch, K.M.A.
Eguchi, T.-a., see Kishi, T. (145) 109 The temporal evolution of MRI tissue signatures after transient mid-
Ewing, J.R., see Jiang, Q. (145) 15 dle cerebral artery occlusion in rat (145) 15
222 Author Index (Vol. 145)
Jiménez-Jiménez, F.J., Rubio, J.C., Molina, J.A., Martin, M.A., Campos, Navon, R., see Hund, E. (145) 25
Y., Benito-Le6én, J., Orti-Pareja, M., Gasalla, T. and Arenas, J. Neidecker, J., see Veuillet, E. (145) 69
Cerebrospinal fluid carnitine levels in patients with Parkinson’s dis- Ng, H.-k., Cheng, Y. and Poon, W.-s.
ease (145) 183 Alzheimer-type of pathological changes in Chinese (145) 97
Johnson, G.J., see Plant, G.T. (145) 127 Nighoghossian, N., see Trouillas, P. (145) 205
Niimi, H., see Takanashi, J.-i. (145) 83
Kajiya, Y., Kajiya, Y. and Nakajo, M. Nishimura, K. and Hung, T.-p.
Age-related changes in cerebral MR angiography (145) 195 Current views on geographic distribution and modes of infection of
Kajiya, Y., see Kajiya, Y. (145) 195 neurohelminthic diseases (145) 5
Kakigi, R., see Kitamura, Y. (145) 187 Nochlin, D., see Van Belle, G. (145) 141
Kalnins, R.M., see Marzuki, S. (145) 155 Nonaka, I., see Suzuki, Y. (145) 49
Kapsa, R.M.I., see Marzuki, S. (145) 155 Nonaka, I., see Takanashi, T. (145) 41
Karbe, H., see Heiss, W.-D. (145) 213
Kessler, J., see Heiss, W.-D. (145) 213 Okino, S.
Khalili-Shirazi, A., Gregson, N.A., Hall, M.A., Hughes, R.A.C. and Familial benign myoclonus epilepsy of adult onset: A previously
Lanchbury, J.S. unrecognized myoclonic disorder (145) 113
T cell receptor VB gene usage in Guillain-Barré syndrome (145) 169 O’Riordan, J., see Giovannoni, G. (145) 77
Kishi, T., Fujita, N., Eguchi, T.-a. and Ueda, K. Orrell, R.W., Habgood, J.J., De Belleroche, J.S. and Lane, R.J.M.
Mechanism for reduction of serum folate by antiepileptic drugs during The relationship of spinal muscular atrophy to motor neuron disease:
prolonged therapy (145) 109 Investigation of SMN and NAIP gene deletions in sporadic and
Kitamura, Y., Kakigi, R., Hoshiyama, M., Koyama, S., Watanabe, S. and familial ALS (145) 55
Shimojo, M. Orti-Pareja, M., see Jiménez-Jiménez, F.J. (145) 183
Pain-related somatosensory evoked magnetic fields following lower Osawa, M., see Shibata, K. (145) 177
limb stimulation (145) 187 Otsuka, M., see Taniwaki, T. (145) 63
Knight, R.A., see Jiang, Q. (145) 15
Kobayashi, T., see Taniwaki, T. (145) 63 Pawlik, G., see Heiss, W.-D. (145) 213
Koyama, S., see Kitamura, Y. (145) 187 Peck, D., see Jiang, Q. (145) 15
Kustermann-Kuhn, B., see Hund, E. (145) 25 Pietrzyk, U., see Heiss, W.-D. (145) 213
Kuwabara, Y., see Taniwaki, T. (145) 63 Plant, G.T., Mtanda, A.T., Arden, G.B. and Johnson, G.J.
Kyriallis, K., see Dean, G. (145) 163 An epidemic of optic neuropathy in Tanzania: Characterization of the
visual disorder and associated peripheral neuropathy (145) 127
Lanchbury, J.S., see Khalili-Shirazi, A. (145) 169 Poon, W.-s., see Ng, H.-k. (145) 97
Land, J.M., see Giovannoni, G. (145) 77 Prilipko, L., see Janca, A. (145) 1
Lane, R.J.M., see Orrell, R.W. (145) 55
Lanska, D.J. Rubio, J.C., see Jiménez-Jiménez, F.J. (145) 183
Comparison of utilization of Sinemet® and Parkinson’s disease mor-
tality as surrogate indicators of Parkinson’s disease in the United Saifuddin Noer, A., see Marzuki, S. (145) 155
States (145) 105 Sakai, T., see Taniwaki, T. (145) 63
Larson, E.B., see Van Belle, G. (145) 141 Sasmono, T., see Marzuki, S. (145) 155
Scarlato, G., see Del Bo, R. (145) 87
Maemoto, T., see Takanashi, J.-i. (145) 83 Schut, L., see Trouillas, P. (145) 205
Manyam, B., see Trouillas, P. (145) 205 Seki, K., see Yuki, N. (145) 119
Martin, M.A., see Jiménez-Jiménez, F.J. (145) 183 Shibata, K., Osawa, M. and Iwata, M.
Marzuki, S., Berkovic, S.F., Saifuddin Noer, A., Kapsa, R.M.I., Kalnins, Pattern reversal visual evoked potentials in classic and common
R.M., Byrne, E., Sasmono, T. and Sudoyo, H. migraine (145) 177
Developmental genetics of deleted mtDNA in mitochondrial oculomy- Shiga, J., see Matsumoto, R. (145) 147
opathy (145) 155 Shimojo, M., see Kitamura, Y. (145) 187
Massaquoi, S., see Trouillas, P. (145) 205 Siest, G., see Merched, A. (145) 33
Masuda, K., see Taniwaki, T. (145) 63 Silva, C., see Janca, A. (145) 1
Matsumoto, R., Nakano, I., Shiga, J. and Akaoka, I. Silver, N.C., see Giovannoni, G. (145) 77
Systemic lupus erythematosus with multiple perivascular spongy Subramony, S.H., see Trouillas, P. (145) 205
changes in the cerebral deep structures, midbrain and cerebellar white Sudoyo, H., see Marzuki, S. (145) 155
matter: A case report (145) 147 Sugita, K., see Takanashi, J.-i. (145) 83
Matsuoka, K., see Suzuki, Y. (145) 49 Sumi, M., see Van Belle, G. (145) 141
Meinck, H.-M., see Hund, E. (145) 25 Suzuki, Y., Goto, Y.-i., Taniyama, M., Nonaka, I., Murakami, N.,
Merched, A., Blain, H., Visvikis, S., Herbeth, B., Jeandel, C. and Siest, Hosokawa, K., Asahina, T., Atsumi, Y. and Matsuoka, K.
G. Muscle histopathology in diabetes mellitus associated with mitochon-
Cerebrospinal fluid apolipoprotein E level is increased in late-onset drial tRNA“YYYR) mutation at position 3243 (145) 49
Alzheimer’s disease (145) 33 Suzuki, Y., see Takanashi, T. (145) 41
Middleton, L., see Dean, G. (145) 163
Miller, R.F., see Giovannoni, G. (145) 77 Takanashi, J.-i., Sugita, K., Tanabe, Y., Maemoto, T. and Niimi, H.
Molina, J.A., see Jiménez-Jiménez, F.J. (145) 183 Dichloroacetate treatment in Leigh syndrome caused by mitochondrial
Mtanda, A.T., see Plant, G.T. (145) 127 DNA mutation (145) 83
Murakami, N., see Suzuki, Y. (145) 49 Takanashi, T., Suzuki, Y., Yoshino, Y. and Nonaka, I.
Granulomatous myositis: pathologic re-evaluation by immunohisto-
Nakajo, M., see Kajiya, Y. (145) 195 chemical analysis of infiltrating mononuclear cells (145) 41
Nakano, I., see Matsumoto, R. (145) 147 Takayanagi, T., see Trouillas, P. (145) 205
Author Index (Vol. 145)
Tanabe, Y., see Takanashi, J.-i. (145) 83 technicians and pathologists (145) 141
Taniwaki, T., Sakai, T., Kobayashi, T., Kuwabara, Y., Otsuka, M., Veuillet, E., Gartner, M., Champsaur, G., Neidecker, J. and Collet, L.
Ichiya, Y., Masuda, K. and Goto, I. Effects of hypothermia on cochlear micromechanical properties in
Positron emission tomography (PET) in Machado-Joseph disease humans (145) 69
(145) 63 Visvikis, S., see Merched, A. (145) 33
Taniyama, M., see Suzuki, Y. (145) 49
Thompson, E.J., see Giovannoni, G. (145) 77 Wakabayashi, K., see Yuki, N. (145) 119
Timann, D., see Trouillas, P. (145) 205 Watanabe, S., see Kitamura, Y. (145) 187
Trouillas, P., Takayanagi, T., Hallett, M., Currier, R.D., Subramony, Weber-Luxenburger, G., see Heiss, W.-D. (145) 213
S.H., Wessel, K., Bryer, A., Diener, H.C., Massaquoi, S., Gomez, Welch, K.M.A., see Jiang, Q. (145) 15
C.M., Coutinho, P., Ben Hamida, M., Campanella, G., Filla, A., Wessel, K., see Trouillas, P. (145) 205
Schut, L., Timann, D., Honnorat, J., Nighoghossian, N. and Manyam, Windham, J.P., see Jiang, Q. (145) 15
B.
International Cooperative Ataxia Rating Scale for pharmacological Yamada, M., see Yuki, N. (145) 119
assessment of the cerebellar syndrome (145) 205 Yoshino, Y., see Takanashi, T. (145) 41
Yuki, N., Wakabayashi, K., Yamada, M. and Seki, K.
Ueda, K., see Kishi, T. (145) 109 Overlap of Guillain-Barré syndrome and Bickerstaff’s brainstem en-
cephalitis (145) 119
Van Belle, G., Gibson, K., Nochlin, D., Sumi, M. and Larson, E.B.
Counting plaques and tangles in Alzheimer’s disease: Concordance of Zhang, Z.G., see Jiang, Q. (145) 15
JOURNAL OF THE
NEUROLOGICAL
SCIENCES
rm AA
ELSEVIER Journal of the Neurological Sciences 145 (1997) 225-226
Subject Index (Vol. 145)
Accuracy, (145) 141 Focal cerebral ischemia, (145) 15
Acetazolamide, (145) 123 Folate deficiency, (145) 109
Action myoclonus, (145) 123
Activation, (145) 213 GBS, (145) 169
Age, (145) 195
Genetics, (145) 55
AIDP, (145) 169 Geographic distribution, (145) 5
AIDS, (145) 77j Geography, (145) 105
Alzheimer’s disease, (145) 87, 97, 141 Gyo gangliosidosis, (145) 25
Alzheimer’s disease (AD), (145) 33 Giant SEP, (145) 113
Alzheimer-type change, (145) 97 Glucose, (145) 63
Amyloid, (145) 87 Glucose metabolism, (145) 213
Amyotrophic lateral sclerosis, (145) 55 Granulomatous myositis, (145) 41
Antiepileptic drug, (145) 109 Guillain-Barré syndrome, (145) 119
Anti-GQ1b antibody, (145) 119
Aphasia, (145) 213
Hexosaminidase, (145) 25
Apolipoprotein E4, (145) 87 High amplitude VEP, (145) 177
Apolipoprotein E (apoE), (145) 33 Histopathology, (145) 15
Aspirin, (145) 93
HIV-1, (145) 77
Ataxia, (145) 25 Host-parasite relationship, (145) 5
Autopsy, (145) 119 Human, (145) 69
Autosomal dominant inheritance, (145) 113 Human mtDNA, (145) 155
‘ Hypothermia, (145) 69
Bickerstaff’s brainstem encephalitis, (145) 119
en pea Ee Improvement of language performance, (145) 213
Carbamazepine, (145) 109 Ischemic stroke, (145) 93
Camitine, (145) 183
Causative agents, (145) 5 Jerk-locked back averaging, (145) 113
Cerebellar ataxia, (145) 63, 205
Cerebral artery, (145) 195 Lactate, (145) 83
Cerebrospinal fluid, (145) 183 Lacunar infarction, (145) 195
Cerebrospinal fluid (CSF), (145) 33 Leigh syndrome, (145) 83
Chinese, (145) 97
Cingulate cortex, (145) 187 Machado-Joseph disease, (145) 63
Cluster analysis, (145) 15 Magnetic resonance angiography (MRA), (145) 195
Cognitive ability, (145) 87 Magnetic resonance imaging, (145) 83
Concordance, (145) 141 Magnetic resonance imaging (MRI), (145) 15
Controlled double-blind drug placebo studies, (145) 205 Magnetoencephalography, (145) 187
Cooperative international trials, (145) 205 Mental retardation, (145) 87
Cortical spreading depression, (145) 177 Metabolic cochlear mechanism, (145) 69
C reflex, (145) 113 Migraine, (145) 177
Mitochondrial disorder, (145) 155
Demography, (145) 105 Mitochondrial encephalomyopathy, lactic acidosis, and _ stroke-like
Diabetes mellitus associated with 3243 mitochondrial tRNA mutation, episodes (MELAS), (145) 49
(145) 49 Mitochondrial function, (145) 183
Diffusion, (145) 15 Mode of infection, (145) 5
mtDNA deletion, (145) 155 Motor neuron disease, (145) 25
mtDNA heteroplasmy, (145) 155 Multiple sclerosis, (145) 77, 163
Dopamine, (145) 63 Muscle pathophysiology, (145) 49
Down’s syndrome, (145) 87 Myoclonus epilepsy, (145) 113
Education, (145) 1 NAIP, (145) 55
Embryonic tissue distribution, (145) 155 Neurohelminthiasis, (145) 5
Enzyme induction, (145) 109 Neurological diseases, (145) 33
Epidemiology, (145) 105 Neurological disorder, (145) 1
226 Subject Index (Vol. 145)
Neurology, (145) 1 Serum, (145) 77
Neuropathology, (145) 141 Sex, (145) 195
Neuropsychiatric manifestation, (145) 147 SMN, (145) 55
Nitrate, (145) 77 Sodium dichloroacetate, (145) 83
Nitric oxide, (145) 77 Somatosensory evoked magnetic fields, (145) 187
Nitrite, (145) 77 Speech related areas, (145) 213
Spheroid, (145) 147
Olivopontocerebellar atrophy, (145) 63 Spinal muscular atrophy, (145) 25, 55
Opportunistic infection, (145) 5 Spongy degeneration, (145) 147
Outcome, (145) 93 Statistics, (145) 105
Oxidative stress, (145) 183 Sural nerve, (145) 187
Systemic lupus erythematosus, (145) 147
Painful stimulation, (145) 187
Parkinson’s disease, (145) 105, 183 Tangle, (145) 141
PET, (145) 213 Tay-Sachs disease, (145) 25
Phenobarbitone, (145) 109 T cell receptor, (145) 169
Phenotype of infiltrating cells, (145) 41 Temperature, (145) 69
Plaque, (145) 141 Transient-evoked otoacoustic emission, (145) 69
Plasma, (145) 183 Tropical /nutritional optic neuropathy, (145) 127
Positron emission tomography, (145) 63 Tropical /nutritional peripheral neuropathy, (145) 127
Precision, (145) 141 Turkish Cypriot males high prevalence, (145) 163
Prevention, (145) 1
Progressive muscular atrophy, (145) 55 UNHCR Bicommunal Study, (145) 163
Proton magnetic resonance spectroscopy, (145) 83 United States, (145) 105
Public health, (145) 1
Valproic acid, (145) 109
Ragged red fiber, (145) 49 VB gene, (145) 169
Ramsay Hunt syndrome, (145) 123 Visual evoked potentials (VEPs), (145) 177
Rat, (145) 15
Rating scale, (145) 205 Weakness, (145) 25
Risk factor, (145) 105 World Federation of Neurology, (145) 205
World Health Organization, (145) 1
Sarcoidosis, (145) 41
Second sensory cortex, (145) 187 Zonisamide, (145) 109
